Business Description
Genenta Science is an Italian biotech company founded in 2014 and based in Milan, focused on using modified stem cells to fight solid tumors. Its main therapy, Temferon, is currently in early-phase clinical trials as a treatment for an aggressive form of brain cancer and is also being explored for liver cancers. The company's broader research centers on a platform designed to deliver cancer-fighting molecules directly into tumors through the body's own immune cells.
